Dichloroacetate treatment for adult patients with mitochondrial disease

Clinical Neurology

Volumn 43, Issue 4, 2003, Pages 154-161

  Oishi, Kenichi ^a   Yoshioka, Masayuki ^a   Ozawa, Ritsuko ^a   Yamamoto, Toshiyuki ^a   Oya, Yasushi ^a   Ogawa, Masafumi ^a   Kawai, Mitsuru ^a  

^a NONE

Author keywords

Adult patients; Consciousness disturbances; Dichloroacetate; Mitochondrial disease; Peripheral neuropathy

Indexed keywords

C PEPTIDE; DICHLOROACETIC ACID; INSULIN; LACTIC ACID; PYRUVIC ACID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CONVULSION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DOSE RESPONSE; DRUG MECHANISM; ELECTROENCEPHALOGRAM; FATIGUE; FEMALE; GAIT DISORDER; GENE MUTATION; HEADACHE; HEARING DISORDER; HEARING LOSS; HEMIANOPIA; HEREDITARY OPTIC ATROPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JAPAN; LACTATE BLOOD LEVEL; MALE; MENTAL DETERIORATION; MUSCLE ATROPHY; MUSCLE CRAMP; NERVE CONDUCTION; NERVE POTENTIAL; POLYNEUROPATHY; RISK BENEFIT ANALYSIS; SENSORY DYSFUNCTION; SENSORY NERVE; SLOW BRAIN WAVE; TENDON REFLEX;

EID: 0041810379     PISSN: 0009918X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 2. Brain Dev 19: 262-267, 1997
2. 31P NMR study. Neurology 39: 399-403, 1989
3. Shoffner JM, Lott MT, Voljavec AS, et al: Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: A slip-replication model and metabolic therapy. Proc Natl Acad Sci USA 86: 7952-7956, 1989
4. Campos Y, Huertas R, Lorenzo G, et al: Plasma carnitine insufficiency and effectiveness of L-carnitine therapy in patients with mitochondrial myopathy. Muscle Nerve 16: 150-153, 1993
5. Walker UA, Byrne E: The therapy of respiratory chain encephalomyopathy: a critical review of the past and current perspective. Acta Neurol Scand 92: 273-280, 1995
6. Stacpoole PW: The pharmacology of dichloroacetate. Metabolism 38: 1124-1144, 1989
7. Kuroda Y, Ito M, Toshima K, et al: Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate. J Inherit Metab Dis 9: 244-252, 1986
8. Saitoh S, Momoi MY, Yamagata T, et al: Effects of dichloroacetate in three patients with MELAS. Neurology 50: 531-534, 1998
9. De Stefano N, Matthews PM, Ford B, et al: Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders. Neurology 45: 1993-1998, 1995
10. Pavlakis SG, Kingsley PB, Kaplan GP, et al: Magnetic resonance spectroscopy: use in monitoring MELAS treatment. Arch Neurol 55: 849-852, 1998
11. Saijo T, Naito E, Ito M, et al: Therapeutic effect of sodium dichloroacetate on visual and auditory hallucinations in a patient with MELAS. Neuropediatrics 22: 166-167, 1991
12. 1 for lactic acidemia in children with MELAS syndrome. J Pediatr 131: 450-452, 1997
13. Naito E, Kuroda Y, Toshima K, et al: Effect of sodium dichloroacetate on human pyruvate metabolism. Brain Dev 11: 195-197, 1989
14. Spruijt L, Naviaux RK, McGowan KA, et al: Nerve conduction changes in patients with mitochondrial diseases treated with dichloroacetate. Muscle Nerve 24: 916-924, 2001
15. Curry SH, Chu PI, Baumgartner TG, et al: Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther 37: 89-93, 1985
16. Stacpoole PW, Moore GW, Kornhauser DM.: Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia. N Engl J Med 298: 526-530, 1978
17. Clark AS, Mitch WE, Goodman MN, et al: Dichloroacetate inhibits glycolysis and augments insulin-stimulated glycogen synthesis in rat muscle. J Clin Invest 79: 588-594, 1987
18. Diamond MP, Suhrer JH Jr, Williams PE, et al: Contribution of the liver and extrasplanchnic tissues to the hypoglycemic action of dichloroacetate in the conscious dog. Diabetes 31: 326-332, 1982
19. Sener A, Kawazu S, Hutton JC, et al: The stimulus-secretion coupling of glucose-induced insulin release. Effect of exogenous pyruvate on islet function. Biochem J 176: 217-232, 1978
20. Otabe S, Yasuda K, Mori Y, et al: Molecular and histological evaluation of pancreata from patients with a mitochondrial gene mutation associated with impaired insulin secretion. Biochem Biophys Res Commun 259: 149-156, 1999
21. Stacpoole PW, Moore GW, Kornhauser DM: Toxicity of chronic dichloroacetate. N Engl J Med 300: 372, 1979
22. Kurlemann G, Paetzke I, Möller H, et al: Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy. Eur J Pediatr 154: 928-932, 1995
23. Stacpoole PW, Harwood HJ Jr, Cameron DF, et al: Chronic toxicity of dichloroacetate: possible relation to thiamine deficiency in rats. Fundam Appl Toxicol 14: 327-337, 1990
24. Wargovich TJ, MacDonald RG, Hill JA, et al: Myocardial metabolic and hemodynamic effects of dichloroacetate in coronary artery disease. Am J Cardiol 61: 65-70, 1988